Eidos Therapeutics Inc (EIDX) Stock Analyst Ratings
NASDAQ:EIDX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 55% to EIDX. The Buy consensus is the weighted average rating of the current analysts ratings.
EIDX was analyzed by 8 analysts. The buy percentage consensus is at 55. So analysts seem to be rather neutral about EIDX.
In the previous month the buy percentage consensus was at a similar level.
EIDX was analyzed by 8 analysts. More opinions would make the average more meaningful.